Exalpha提供用以臨床免疫組化實驗的抗體，和常規(guī)研究用的信號通路抗體，流式細胞用的CD?markers，細胞增殖實驗檢測產(chǎn)品，Elisa試劑盒及用于藥物發(fā)現(xiàn)用的GPCR膜制劑等。
??

?抗體	?酶/蛋白	?試劑盒
?● 臨床IHC標志分子抗體	?●?合成蛋白	?●?細胞增殖檢測試劑盒
?●?CD分子抗體	?●?重組蛋白	?●?細胞凋亡檢測試劑盒
?	?●?活性酶	?●?ELISA試劑盒
?	?●?純化蛋白	?●?GPCR膜制劑
?	?●?對照裂解物	?●?GPCR抗體及相關產(chǎn)品
?	?	?●?流式試劑盒

特色產(chǎn)品推薦

●?細胞增殖與檢測試劑盒
評估細胞周期進程在許多研究領域都非常重要，傳統(tǒng)的方法是將[3H]胸腺嘧啶核苷摻入S期細胞，然后通過閃爍計數(shù)或放射自顯影來定量[3H],?以此來檢測細胞增殖，但該技術流程耗時且費力，還有許多限制因素比如同位素污染處理和設備昂貴等問題。

- BrdU?Proliferation?Colorimetric?ELISA?Kit
-?BrdU?Proliferation?Chemiluminescent?ELISA?Kit
-?BrdU?Proliferation?Immunohistochemistry?Kit
-?BrdU?Antibodies
-?ApoMark??Apoptosis?Kit

●?GPCR?膜制備品?(GPCR?Membrane?Preparations)
Exalpha提供的EDG受體功能性膜制備物來自過表達EDG受體的重組細胞系。這些細胞系經(jīng)裂解和純化，僅含有功能性EDG受體及偶聯(lián)的G蛋白。非常適用于配體誘導的[35S]GTPgs結合實驗。


?

?產(chǎn)品編號	?產(chǎn)品名稱
?X1274MP	?Lysophosphatidic?Acid?Receptor?1?(EDG2)?Membrane?Preparation
?X1546MP?	?Lysophosphatidic?Acid?Receptor?2?(EDG-4)?Membrane?Preparation
?X1275MP	?Lysophosphatidic?Acid?Receptor?3?(EDG-7)?Membrane?Preparation
?X1273MP	?Sphingosine?1?Phosphate?Receptor?1?(EDG-1)?Membrane?Preparation

?
●?GPCR?抗體及相關產(chǎn)品

?產(chǎn)品編號	?產(chǎn)品名稱
?X2106P ? ? ? ??	?5-HT5A?Receptor?(HTR5A)?Antigen?Immunoaffinity?Purified?Polyclonal
?X2110P	?5-HT5A?Receptor?(HTR5A)?Antigen?Immunoaffinity?Purified?Polyclonal
?X2142P	?5-HT5A?Receptor?(HTR5A)?Antigen?Immunoaffinity?Purified?Polyclonal
?X2140P	?5-HT7?Receptor?(HTR7)?Antigen?Immunoaffinity?Purified?Polyclonal
?X2141P	?5-HT7?Receptor?(HTR7)?Antigen?Immunoaffinity?Purified?Polyclonal
?X2152P	?5-HT7?Receptor?(HTR7)?Antigen?Immunoaffinity?Purified?Polyclonal
?X1630M	?alpha2B?Adrenergic?Receptor?Monoclonal?Antibody
?X1687P	?Metabotropic?Glutamate?Receptor?1a?Polyclonal?Antibody
?X1688P	?Metabotropic?Glutamate?Receptor?2/3?Polyclonal?Antibody
?X1689P	?Metabotropic?Glutamate?Receptor?5/1a?Polyclonal?Antibody
?X1655P?	?GPR3?Antigen?Immunoaffinity?Purified?Polyclonal
?X1638P	?GPR4?Antigen?Immunoaffinity?Purified?Polyclonal
?X1646B	?GPR4?Blocking?Peptide?Blocking?Peptide
?X1570P	?Lysophosphatidic?Acid?2?(LPA2)?Receptor?(EDG4)?CT?Polyclonal?Antibody
?c174p ?	?Lysophosphatidic?Acid?Receptor?1?CT?(EDG-2)?Polyclonal?Antibody
?X1269B	?Lysophosphatidic?Acid?Receptor?1?CT?(EDG-2)?Blocking?Peptide
?X1573B	?Lysophosphatidic?Acid?Receptor?2?(EDG4)?CT?Blocking?Peptide
?X1183P	?Lysophosphatidic?Acid?Receptor?3?CT?(EDG-7)?Polyclonal?Antibody
?X1227B	?Lysophosphatidic?Acid?Receptor?3?CT?(EDG-7)?Blocking?Peptide
?X1600P?	?OGR1/GPR68?Polyclonal?Antibody
?X1601C	?OGR1/GPR68?Control?Lysate
?X2333P?	?SMO?(Smoothened?Homolog)?Antigen?Immunoaffinity?Purified?Polyclonal
?X2376P	?SMO?(Smoothened?Homolog)?Polyclonal?Antibody
?X2377B	?SMO?(Smoothened?Homolog)?Blocking?Peptide
?X1093P	?Sphingosine?1?Phosphate?Receptor?1?(EDG-1)?CT?Polyclonal?Antibody
?X1224B?	?Sphingosine?1?Phosphate?Receptor?1?(EDG-1)?CT?Blocking?Peptide
?X1094P?	?Sphingosine?1?Phosphate?Receptor?5?CT?(EDG-8)?Polyclonal?Antibody
?X1228B	?Sphingosine?1?Phosphate?Receptor?5?CT?(EDG-8)?Blocking?Peptide
?c176m	?Sphingosine?1?Phosphate?3?Receptor?(EDG-3)?CT?Monoclonal?Antibody
?X1589P?	?Sphingosine?1?Phosphate?3?Receptor?(EDG-3)?CT?Polyclonal?Antibody
?X1690B	?Sphingosine?1?Phosphate?3?Receptor?(EDG-3)?CT?Blocking?Peptide
?X1590P	?Sphingosine?1?Phosphate?3?Receptor?(EDG-3)?NT?Polyclonal?Antibody
?X1182P	?Sphingosine?1?Phosphate?4?Receptor?(CT)?(EDG6)?Polyclonal?Antibody
?X1312B?	?Sphingosine?1?Phosphate?4?Receptor?(CT)?(EDG6)?Blocking?Peptide
?X1533M	?Sphingosine?1?Phosphate?4?Receptor?(CT)?(EDG6)?Monoclonal?Antibody
?X1626M	?Sphingosine?1?Phosphate?4?Receptor?(CT)?(EDG6)?FITC?Conjugate?Monoclonal?Antibody
?X1592P?	?Sphingosine?1?Phosphate?4?Receptor?(IN)?(EDG6)?Polyclonal?Antibody
?X1593P?	?Sphingosine?1?Phosphate?4?Receptor?(NT)?(EDG6)?NT?Polyclonal?Antibody
?Z135M	?VipR?1?(Vasoactive?Intestinal?Peptide?Rec-1)?Monoclonal?Antibody